{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:41:19Z","timestamp":1793148079935,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jpsychires.2021.09.018","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T06:32:52Z","timestamp":1630650772000},"page":"230-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials"],"prefix":"10.1016","volume":"143","author":[{"given":"Francesco","family":"Bartoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5342-9394","authenticated-orcid":false,"given":"Daniele","family":"Cavaleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-0490","authenticated-orcid":false,"given":"Bianca","family":"Bachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-8204","authenticated-orcid":false,"given":"Federico","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Riboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Crocamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Carr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpsychires.2021.09.018_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-013-3397-x","article-title":"Tamoxifen use for the management of mania: a review of current preclinical evidence","volume":"231","author":"Armani","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"issue":"3","key":"10.1016\/j.jpsychires.2021.09.018_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0706743720970857","article-title":"Comparative efficacy and tolerability of adjunctive pharmacotherapies for acute bipolar depression: a systematic review and network meta-analysis","volume":"66","author":"Bahji","year":"2021","journal-title":"Can. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.09.018_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109922","article-title":"Glial and neuronal markers in bipolar disorder: a meta-analysis testing S100B and NSE peripheral blood levels","volume":"101","author":"Bartoli","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib5","article-title":"The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites","author":"Bartoli","year":"2020","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1192\/bjp.bp.115.180281","article-title":"Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials","volume":"210","author":"Bartoli","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2016.09.011","article-title":"Purinergic system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study","volume":"73","author":"Bartoli","year":"2017","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpsychires.2016.07.007","article-title":"Uric acid levels in subjects with bipolar disorder: a comparative meta-analysis","volume":"81","author":"Bartoli","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2015.12.006","article-title":"Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: a systematic review","volume":"74","author":"Bauer","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10128","key":"10.1016\/j.jpsychires.2021.09.018_bib11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"9799","key":"10.1016\/j.jpsychires.2021.09.018_bib12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib13","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/11587620-000000000-00000","article-title":"If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies","volume":"71","author":"Connolly","year":"2011","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.jpsychires.2021.09.018_bib15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.4088\/JCP.13r08851","article-title":"A review of the use of stimulants and stimulant alternatives in treating bipolar depression and major depressive disorder","volume":"75","author":"Corp","year":"2014","journal-title":"J. Clin. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.09.018_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bdi.12601","article-title":"An update on adjunctive treatment options for bipolar disorder","volume":"20","author":"Dean","year":"2018","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/wps.20481","article-title":"The promise and challenges of drug repurposing in psychiatry","volume":"17","author":"Fava","year":"2018","journal-title":"World Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.09.018_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bdi.12423","article-title":"The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013","volume":"18","author":"Ferrari","year":"2016","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.09.018_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/wps.20672","article-title":"The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials","volume":"18","author":"Firth","year":"2019","journal-title":"World Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.09.018_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ebmental-2018-300014","article-title":"Ten simple rules for conducting umbrella reviews","volume":"21","author":"Fusar-Poli","year":"2018","journal-title":"Evid. Base Ment. Health"},{"issue":"9878","key":"10.1016\/j.jpsychires.2021.09.018_bib21","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40345-018-0133-9","article-title":"Antidepressants in bipolar depression: an enduring controversy","volume":"6","author":"Gitlin","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"issue":"12","key":"10.1016\/j.jpsychires.2021.09.018_bib23","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"7650","key":"10.1016\/j.jpsychires.2021.09.018_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41380-020-0831-4","article-title":"Advances toward precision medicine for bipolar disorder: mechanisms & molecules","volume":"26","author":"Haggarty","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.09.018_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhealeco.2012.01.004","article-title":"Evergreening, patent challenges, and effective market life in pharmaceuticals","volume":"31","author":"Hemphill","year":"2012","journal-title":"J. Health Econ."},{"issue":"7414","key":"10.1016\/j.jpsychires.2021.09.018_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jpsychires.2021.09.018_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","article-title":"Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial","volume":"7","author":"Husain","year":"2020","journal-title":"Lancet Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.09.018_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1503\/cmaj.081086","article-title":"Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses","volume":"181","author":"Ioannidis","year":"2009","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"issue":"4","key":"10.1016\/j.jpsychires.2021.09.018_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000501210","article-title":"Effect of rivastigmine (acetyl cholinesterase inhibitor) versus placebo on manic episodes in patients with bipolar disorders: results from a double blind, randomized, placebo-controlled clinical trial","volume":"78","author":"Keshavrzi","year":"2019","journal-title":"Neuropsychobiology"},{"issue":"5","key":"10.1016\/j.jpsychires.2021.09.018_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bdi.12772","article-title":"New drug candidates for bipolar disorder-A nation-wide population-based study","volume":"21","author":"Kessing","year":"2019","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib32","article-title":"Melatonin receptor agonists for bipolar mania: a systematic review and meta-analyses of double-blind randomized placebo-controlled trials","author":"Kishi","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.psyneuen.2014.02.004","article-title":"A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania","volume":"43","author":"Kulkarni","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.jpsychires.2021.09.018_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/mp.2009.39","article-title":"Neurobiological trait abnormalities in bipolar disorder","volume":"14","author":"Langan","year":"2009","journal-title":"Mol. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.09.018_bib35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2015.05.001","article-title":"Drug repositioning and repurposing: terminology and definitions in literature","volume":"20","author":"Langedijk","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2018.06.017","article-title":"Mindfulness-based cognitive therapy for bipolar disorder: a systematic review","volume":"240","author":"Lovas","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib37","first-page":"CD011611","article-title":"Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults","volume":"9","author":"McCloud","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10265","key":"10.1016\/j.jpsychires.2021.09.018_bib38","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbi.2020.04.013","article-title":"Chemokine alterations in bipolar disorder: a systematic review and meta-analysis","volume":"88","author":"Misiak","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hup.2369","article-title":"A meta-analysis of inositol for depression and anxiety disorders","volume":"29","author":"Mukai","year":"2014","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib41","article-title":"N-acetylcysteine as an adjunctive treatment for bipolar depression: a systematic review and meta-analysis of randomized controlled trials","author":"Nery","year":"2020","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.09.018_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/bdi.12859","article-title":"Efficacy and tolerability of adjunctive modafinil\/armodafinil in bipolar depression: a meta-analysis of randomized controlled trials","volume":"22","author":"Nunez","year":"2020","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.09.018_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058777","article-title":"Effect sizes for 2\u00d72 contingency tables","volume":"8","author":"Olivier","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.09.018_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0269881118822167","article-title":"Tamoxifen for bipolar disorder: systematic review and meta-analysis","volume":"33","author":"Palacios","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"9878","key":"10.1016\/j.jpsychires.2021.09.018_bib45","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(13)60989-7","article-title":"Bipolar disorder diagnosis: challenges and future directions","volume":"381","author":"Phillips","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib46","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2","article-title":"Chapter V: overviews of reviews","author":"Pollock","year":"2021"},{"issue":"4","key":"10.1016\/j.jpsychires.2021.09.018_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1300\/J079v21n04_02","article-title":"Qualitative descriptors of strength of association and effect size","volume":"21","author":"Rosenthal","year":"1996","journal-title":"J. Soc. Serv. Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.09.018_bib48","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.09.018_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2\u00d72 double-blind, randomized, placebo-controlled, phase IIA clinical trial","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib50","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2","article-title":"Chapter 14: completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2021"},{"key":"10.1016\/j.jpsychires.2021.09.018_bib51","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.09.018_bib52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4088\/JCP.12m08305","article-title":"Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study","volume":"75","author":"Stamm","year":"2014","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.09.018_bib53","series-title":"Stata Statistical Software: Release 16","year":"2019"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.09.018_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/acps.13055","article-title":"Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis","volume":"140","author":"Tundo","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.09.018_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.09.018_bib56","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/npp.2009.2","article-title":"Decreased glutamate\/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study","volume":"34","author":"Yoon","year":"2009","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621005574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621005574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:22:19Z","timestamp":1758367339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395621005574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":56,"alternative-id":["S0022395621005574"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.09.018","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}